← PROCEPT BioRobotics Corp
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.7m |
$34.5m
+346.72%
|
$75.0m
+117.60%
|
$136.2m
+81.55%
|
$224.5m
+64.84%
|
$308.1m
+37.22%
|
$337.3m
+9.51%
|
|
| Cost of sales | $9.0m |
$18.6m
+107.40%
|
$37.9m
+103.83%
|
$65.1m
+71.75%
|
$87.4m
+34.17%
|
$111.8m
+27.95%
|
$120.7m
+7.93%
|
|
| Gross profit | ($1.3m) |
$15.9m
+1364.14%
|
$37.1m
+133.75%
|
$71.0m
+91.58%
|
$137.1m
+92.96%
|
$196.2m
+43.13%
|
$216.6m
+10.41%
|
|
| Research and development | $16.3m | $19.0m | $29.0m | $48.4m | $62.3m | $71.3m | $78.8m | |
| Selling, general and administrative | $30.3m | $51.0m | $88.8m | $131.8m | $171.4m | $228.8m | $252.1m | |
| Total operating expenses | $46.5m | $70.0m | $117.8m | $180.2m | $233.7m | $300.1m | $330.9m | |
| Loss from operations | ($47.8m) |
($54.2m)
-13.31%
|
($80.7m)
-49.04%
|
($109.2m)
-35.24%
|
($96.6m)
+11.50%
|
($103.9m)
-7.50%
|
— | |
| Interest expense | ($5.3m) | ($5.8m) | ($5.2m) | ($4.0m) | ($4.2m) | ($3.6m) | $3.5m | |
| Interest and other income (expenses), net | $44k | $121k | $2.0m | $7.3m | $9.4m | $12.1m | — | |
| Loss before income taxes | — | — | — | ($105.8m) | ($91.0m) | ($95.4m) | — | |
| Provision for income taxes | — | — | — | $80k | $368k | $190k | — | |
| Net loss | ($53.0m) | ($59.9m) | ($87.2m) | ($105.9m) | ($91.4m) | ($95.6m) | — | |
| Net loss per share, basic (in dollars per share) | ($14) | ($4) | ($2) | ($2) | ($2) | ($2) | — | |
| Net loss per share, diluted (in dollars per share) | ($14) | ($4) | ($2) | ($2) | ($2) | ($2) | — | |
| Basic (in shares) | $3.7m | $16.5m | $44.4m | $47.3m | $52.1m | $55.5m | $56.3m | |
| Diluted (in shares) | $3.7m | $16.5m | $44.4m | $47.3m | $52.1m | $55.5m | $56.3m | |
| Foreign currency translation adjustment | — | — | — | $0 | $0 | ($77k) | — | |
| Unrealized gain on cash equivalents | ($18k) | ($40k) | $48k | $90k | $30k | $0 | — | |
| Comprehensive loss | ($53.0m) | ($59.9m) | ($87.1m) | ($105.8m) | ($91.4m) | ($95.6m) | — |